KALA · KALA BIO Inc. Common Stock
View on chartInsiders & Stakes
| RA CAPITAL MANAGEMENT, L.P. Director | ▼ Sell | Open Market | 7,039,613 Shares held | 5/26/2022 | View profile |
| BAKER BROS. ADVISORS LP Director | ▼ Sell | Open Market | 425,006 Shares held | 10/1/2025 | View profile |
| Chen Hongming CHIEF SCIENTIFIC OFFICER | ▼ Sell | Open Market | 204,515 Shares held | 10/27/2021 | View profile |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER | ▼ Sell | Open Market | 103,540 Shares held | 10/23/2025 | View profile |
| Trachtenberg Eric SEE REMARKS | ▼ Sell | Open Market | 68,066 Shares held | 1/4/2024 | View profile |
| Darius Kharabi CHIEF BUSINESS OFFICER | ▼ Sell | Open Market | 41,760 Shares held | 10/22/2025 | View profile |
| Romulus K. Brazzell CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 35,952 Shares held | 10/22/2025 | View profile |
| Todd Bazemore CHIEF OPERATING OFFICER | ▼ Sell | Open Market | 35,932 Shares held | 10/22/2025 | View profile |
| Mary Reumuth CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 28,906 Shares held | 10/23/2025 | View profile |
| Andrew I. Koven Director | ▲ Buy | Grant | 16,972 Shares held | 6/15/2025 | View profile |
| Howard B. Rosen Director | ▲ Buy | Grant | 16,240 Shares held | 6/15/2025 | View profile |
| Gregory D. Perry | ▲ Buy | Grant | 13,344 Shares held | 6/15/2025 | View profile |
| Blumenkranz Mark S. | ▲ Buy | Grant | 13,091 Shares held | 6/11/2024 | View profile |
| C. Daniel Myers | ▲ Buy | Grant | 10,374 Shares held | 6/15/2025 | View profile |
| Marjan Farid | ▲ Buy | Grant | 10,242 Shares held | 6/15/2025 | View profile |
Transaction History
| Mark T. Iwicki | ▼ Sell | Open Market | 154,894 | $125K | 10/23/2025 |
| Mary Reumuth | ▼ Sell | Open Market | 967 | $793 | 10/23/2025 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 46,748 | $39K | 10/22/2025 |
| Darius Kharabi | ▼ Sell | Open Market | 20,806 | $17K | 10/22/2025 |
| Todd Bazemore | ▼ Sell | Open Market | 47,768 | $40K | 10/22/2025 |
| Mary Reumuth | ▼ Sell | Open Market | 32,230 | $27K | 10/22/2025 |
| BAKER BROS. ADVISORS LP | ▼ Sell | Open Market | 50,640 | $70K | 10/1/2025 |
| BAKER BROS. ADVISORS LP | ▼ Sell | Open Market | 462,967 | $641K | 10/1/2025 |
| BAKER BROS. ADVISORS LP | ▼ Sell | Open Market | 195,425 | $312K | 9/30/2025 |
| BAKER BROS. ADVISORS LP | ▼ Sell | Open Market | 21,376 | $34K | 9/30/2025 |
| Darius Kharabi | ▼ Sell | Open Market | 4,511 | $18K | 6/24/2025 |
| Mary Reumuth | ▼ Sell | Open Market | 3,631 | $15K | 6/24/2025 |
| Todd Bazemore | ▼ Sell | Open Market | 4,058 | $16K | 6/24/2025 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 5,251 | $21K | 6/24/2025 |
| Mark T. Iwicki | ▼ Sell | Open Market | 13,227 | $53K | 6/24/2025 |
| Howard B. Rosen | ▲ Buy | Grant | 2,450 | $0 | 6/15/2025 |
| Mark T. Iwicki | ▲ Buy | Grant | 2,450 | $0 | 6/15/2025 |
| Marjan Farid | ▲ Buy | Grant | 2,450 | $0 | 6/15/2025 |
| Gregory D. Perry | ▲ Buy | Grant | 2,450 | $0 | 6/15/2025 |
| C. Daniel Myers | ▲ Buy | Grant | 2,450 | $0 | 6/15/2025 |
| Andrew I. Koven | ▲ Buy | Grant | 3,050 | $0 | 6/15/2025 |
| Darius Kharabi | ▼ Sell | Open Market | 730 | $3K | 6/3/2025 |
| Mary Reumuth | ▼ Sell | Open Market | 2,850 | $11K | 6/3/2025 |
| Todd Bazemore | ▼ Sell | Open Market | 3,390 | $13K | 6/3/2025 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 3,687 | $14K | 6/3/2025 |
| Mark T. Iwicki | ▼ Sell | Open Market | 10,866 | $41K | 6/3/2025 |
| Mary Reumuth | ▼ Sell | Open Market | 1,706 | $13K | 1/6/2025 |
| Romulus K. Brazzell | ▲ Buy | Grant | 10,100 | $0 | 1/6/2025 |
| Darius Kharabi | ▲ Buy | Grant | 10,100 | $0 | 1/6/2025 |
| Darius Kharabi | ▼ Sell | Open Market | 2,021 | $15K | 1/6/2025 |
| Todd Bazemore | ▲ Buy | Grant | 10,100 | $0 | 1/6/2025 |
| Mark T. Iwicki | ▲ Buy | Grant | 22,100 | $0 | 1/6/2025 |
| Todd Bazemore | ▼ Sell | Open Market | 1,993 | $15K | 1/6/2025 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 2,446 | $19K | 1/6/2025 |
| Mark T. Iwicki | ▼ Sell | Open Market | 5,779 | $44K | 1/6/2025 |
| Mary Reumuth | ▲ Buy | Grant | 10,100 | $0 | 1/6/2025 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 30,620 | $197K | 12/30/2024 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 279,939 | $1.8M | 12/30/2024 |
| Todd Bazemore | ▼ Sell | Open Market | 4,653 | $22K | 6/26/2024 |
| Darius Kharabi | ▼ Sell | Open Market | 5,158 | $25K | 6/26/2024 |
| Mary Reumuth | ▼ Sell | Open Market | 4,163 | $20K | 6/26/2024 |
| Mark T. Iwicki | ▼ Sell | Open Market | 15,168 | $72K | 6/26/2024 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 5,489 | $26K | 6/26/2024 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 1,400 | $0 | 6/11/2024 |
| Andrew I. Koven | ▲ Buy | Grant | 1,750 | $0 | 6/11/2024 |
| Howard B. Rosen | ▲ Buy | Grant | 1,400 | $0 | 6/11/2024 |
| Marjan Farid | ▲ Buy | Grant | 1,400 | $0 | 6/11/2024 |
| Gregory D. Perry | ▲ Buy | Grant | 1,400 | $0 | 6/11/2024 |
| C. Daniel Myers | ▲ Buy | Grant | 1,400 | $0 | 6/11/2024 |
| Todd Bazemore | ▼ Sell | Open Market | 2,093 | $13K | 5/31/2024 |
| Darius Kharabi | ▼ Sell | Open Market | 231 | $1K | 5/31/2024 |
| Mark T. Iwicki | ▼ Sell | Open Market | 7,392 | $45K | 5/31/2024 |
| Mary Reumuth | ▼ Sell | Open Market | 1,786 | $11K | 5/31/2024 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 2,002 | $12K | 5/31/2024 |
| Romulus K. Brazzell | ▲ Buy | Grant | 6,500 | $0 | 1/4/2024 |
| Trachtenberg Eric | ▲ Buy | Grant | 4,600 | $0 | 1/4/2024 |
| Darius Kharabi | ▲ Buy | Grant | 4,600 | $0 | 1/4/2024 |
| Darius Kharabi | ▼ Sell | Open Market | 1,385 | $9K | 1/4/2024 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 1,617 | $11K | 1/4/2024 |
| Mark T. Iwicki | ▲ Buy | Grant | 14,300 | $0 | 1/4/2024 |
| Mark T. Iwicki | ▼ Sell | Open Market | 4,539 | $31K | 1/4/2024 |
| Mary Reumuth | ▼ Sell | Open Market | 1,227 | $8K | 1/4/2024 |
| Todd Bazemore | ▲ Buy | Grant | 6,500 | $0 | 1/4/2024 |
| Todd Bazemore | ▼ Sell | Open Market | 1,405 | $9K | 1/4/2024 |
| Mary Reumuth | ▲ Buy | Grant | 4,600 | $0 | 1/4/2024 |
| Trachtenberg Eric | ▼ Sell | Open Market | 1,227 | $8K | 1/4/2024 |
| Howard B. Rosen | ▲ Buy | Grant | 7,988 | $0 | 6/22/2023 |
| Andrew I. Koven | ▲ Buy | Grant | 7,515 | $0 | 6/22/2023 |
| Marjan Farid | ▲ Buy | Grant | 3,692 | $0 | 6/22/2023 |
| Marjan Farid | ▲ Buy | Grant | 1,100 | $0 | 6/22/2023 |
| C. Daniel Myers | ▲ Buy | Grant | 3,784 | $0 | 6/22/2023 |
| C. Daniel Myers | ▲ Buy | Grant | 1,100 | $0 | 6/22/2023 |
| Darius Kharabi | ▲ Buy | Grant | 36,847 | $0 | 6/22/2023 |
| Gregory D. Perry | ▲ Buy | Grant | 5,856 | $0 | 6/22/2023 |
| Gregory D. Perry | ▲ Buy | Grant | 1,100 | $0 | 6/22/2023 |
| Todd Bazemore | ▲ Buy | Grant | 48,698 | $0 | 6/22/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 3,784 | $0 | 6/22/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 1,100 | $0 | 6/22/2023 |
| Trachtenberg Eric | ▲ Buy | Grant | 37,559 | $0 | 6/22/2023 |
| Mary Reumuth | ▲ Buy | Grant | 36,144 | $0 | 6/22/2023 |
| Romulus K. Brazzell | ▲ Buy | Grant | 49,356 | $0 | 6/22/2023 |
| Mark T. Iwicki | ▲ Buy | Grant | 158,873 | $0 | 6/22/2023 |
| Howard B. Rosen | ▲ Buy | Grant | 1,100 | $0 | 6/22/2023 |
| Andrew I. Koven | ▲ Buy | Grant | 1,400 | $0 | 6/22/2023 |
| Trachtenberg Eric | ▲ Buy | Grant | 15,639 | — | 5/31/2023 |
| Gregory D. Perry | ▲ Buy | Grant | 1,738 | — | 5/31/2023 |
| Howard B. Rosen | ▲ Buy | Grant | 2,502 | — | 5/31/2023 |
| Marjan Farid | ▲ Buy | Grant | 1,600 | — | 5/31/2023 |
| Darius Kharabi | ▲ Buy | Grant | 2,648 | — | 5/31/2023 |
| C. Daniel Myers | ▲ Buy | Grant | 1,640 | — | 5/31/2023 |
| Andrew I. Koven | ▲ Buy | Grant | 2,197 | — | 5/31/2023 |
| Mary Reumuth | ▲ Buy | Grant | 14,736 | — | 5/31/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 1,640 | — | 5/31/2023 |
| Romulus K. Brazzell | ▲ Buy | Grant | 17,916 | — | 5/31/2023 |
| Todd Bazemore | ▲ Buy | Grant | 21,158 | — | 5/31/2023 |
| Mark T. Iwicki | ▲ Buy | Grant | 71,715 | — | 5/31/2023 |
| Darius Kharabi | ▲ Buy | Grant | 6,977 | — | 3/10/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 2,013 | — | 3/10/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 65,634 | — | 3/10/2023 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 497 | — | 3/10/2023 |
| Blumenkranz Mark S. | ▼ Sell | Other | 3 | — | 2/15/2023 |
| Blumenkranz Mark S. | ▼ Sell | Other | 68 | — | 2/15/2023 |
| Blumenkranz Mark S. | ▼ Sell | Other | 2 | — | 2/15/2023 |
| Darius Kharabi | ▲ Buy | Grant | 9,525 | $0 | 1/4/2023 |
| Trachtenberg Eric | ▲ Buy | Grant | 9,525 | $0 | 1/4/2023 |
| Trachtenberg Eric | ▼ Sell | Open Market | 60 | $2K | 1/4/2023 |
| Mary Reumuth | ▲ Buy | Grant | 9,525 | $0 | 1/4/2023 |
| Mary Reumuth | ▼ Sell | Open Market | 60 | $2K | 1/4/2023 |
| Romulus K. Brazzell | ▲ Buy | Grant | 12,800 | $0 | 1/4/2023 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 73 | $2K | 1/4/2023 |
| Todd Bazemore | ▲ Buy | Grant | 12,800 | $0 | 1/4/2023 |
| Todd Bazemore | ▼ Sell | Open Market | 62 | $2K | 1/4/2023 |
| Mark T. Iwicki | ▲ Buy | Grant | 41,700 | $0 | 1/4/2023 |
| Mark T. Iwicki | ▼ Sell | Open Market | 198 | $6K | 1/4/2023 |
| Trachtenberg Eric | ▼ Sell | Open Market | 194 | $1K | 10/26/2022 |
| Todd Bazemore | ▼ Sell | Open Market | 214 | $1K | 10/26/2022 |
| Mary Reumuth | ▼ Sell | Open Market | 194 | $1K | 10/26/2022 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 261 | $2K | 10/26/2022 |
| Mark T. Iwicki | ▼ Sell | Open Market | 561 | $4K | 10/26/2022 |
| Trachtenberg Eric | ▼ Sell | Open Market | 2,613 | $967 | 6/27/2022 |
| Mary Reumuth | ▼ Sell | Open Market | 2,613 | $967 | 6/27/2022 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 3,144 | $1K | 6/27/2022 |
| Todd Bazemore | ▼ Sell | Open Market | 3,092 | $1K | 6/27/2022 |
| Mark T. Iwicki | ▼ Sell | Open Market | 7,975 | $3K | 6/27/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 1,005,686 | $366K | 5/26/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 1,434,509 | $602K | 5/25/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 144,805 | $74K | 5/24/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 1,250,000 | $813K | 5/23/2022 |
| Darius Kharabi | ▼ Sell | Other | 9 | — | 2/15/2022 |
| Mary Reumuth | ▼ Sell | Open Market | 2,850 | $4K | 1/4/2022 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 3,504 | $5K | 1/4/2022 |
| Todd Bazemore | ▼ Sell | Open Market | 3,454 | $4K | 1/4/2022 |
| Mark T. Iwicki | ▼ Sell | Open Market | 9,518 | $12K | 1/4/2022 |
| Trachtenberg Eric | ▼ Sell | Open Market | 2,850 | $4K | 1/4/2022 |
| Darius Kharabi | ▲ Buy | Grant | 295,657 | — | 11/15/2021 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 157,765 | — | 11/15/2021 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 5,144,390 | — | 11/15/2021 |
| Blumenkranz Mark S. | ▲ Buy | Grant | 38,965 | — | 11/15/2021 |
| Chen Hongming | ▼ Sell | Open Market | 21,051 | $38K | 10/27/2021 |
| Mary Reumuth | ▼ Sell | Open Market | 9,449 | $17K | 10/26/2021 |
| Trachtenberg Eric | ▼ Sell | Open Market | 9,449 | $17K | 10/26/2021 |
| Mark T. Iwicki | ▼ Sell | Open Market | 27,598 | $50K | 10/26/2021 |
| Todd Bazemore | ▼ Sell | Open Market | 12,544 | $23K | 10/26/2021 |
| Romulus K. Brazzell | ▼ Sell | Open Market | 12,757 | $23K | 10/26/2021 |
| Chen Hongming | ▼ Sell | Open Market | 9,449 | $17K | 10/26/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
KALA Bio Signs LOI to Acquire Telehealth Platform
KALA Bio shares surged 57% after hours following the announcement of a non-binding letter of intent to acquire a nationwide telehealth platform. The target company has generated approximately $48 million in sales since inception. Additionally, the company signed a separate agreement to resell genetic testing products through a U.S. DNA testing platform.
KALA Bio Signs LOI to Acquire Telehealth Platform. KALA Bio shares surged 57% after hours following the announcement of a non-binding letter of intent to acquire a nationwide telehealth platform. The target company has generated approximately $48 million in sales since inception. Additionally, the company signed a separate agreement to resell genetic testing products through a U.S. DNA testing platform.